Search research articles
Contact Us
Filters
Showing results (41-50 of 94) with videos related to
Page
of 10
Sort By:
Blood Advances
|
July 27, 2022
Gender and early-career faculty disparities in hematology and oncology board review lecture series
Sebawe Syaj, Leen Al-Kraimeen, Marah Akhdar, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 19, 2021
How to Treat High-Risk Myeloma at Diagnosis and Relapse
Jessica Caro, Samer Al Hadidi, Saad Usmani, et al.
Rheumatology International
|
January 4, 2025
Safety and efficacy of CAR-T cell therapy in patients with autoimmune diseases: a systematic review
Lakshmi Kattamuri, Bhavesh Mohan Lal, Nikhil Vojjala, et al.
Journal of Cancer Policy
|
December 20, 2022
Analysis of repeated roles in editorial boards at oncology focused journals
Lama Sawalha, Amar H Kelkar, Ghulam Rehman Mohyuddin, et al.
Journal of Oncology
|
August 17, 2018
Clinical and Molecular Characteristics Associated with Survival in Advanced Melanoma Treated with Checkpoint Inhibitors
Sunil Badami, Sunil Upadhaya, Ravi Kanth Velagapudi, et al.
Ejhaem
|
June 19, 2024
B-cell maturation antigen-based therapies post-talquetamab in relapsed or refractory multiple myeloma
Asis Shrestha, Marah Alzubi, Jawad Alrawabdeh, et al.
Journal of Cancer Policy
|
July 19, 2023
Under-representation of black patients with multiple myeloma in studies supporting International Myeloma Working Group guidelines
Suhib Fahmawi, Carolina Schinke, Sharmilan Thanendrarajan, et al.
Ejhaem
|
August 19, 2024
Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab
Syed Naqvi, Asis Shrestha, Marah Alzubi, et al.
JAMA Network Open
|
August 26, 2022
Geographic and Racial Disparities in Access to Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials for Multiple Myeloma
Raghad Alqazaqi, Carolina Schinke, Sharmilan Thanendrarajan, et al.
American Journal of Hematology
|
March 31, 2022
First- versus second-generation Bruton tyrosine kinase inhibitors in Waldenström's Macroglobulinemia: A systematic review and meta-analysis
Hassan Abushukair, Sebawe Syaj, Obada Ababneh, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 94) with videos related to
Sort By:
Page
of 10
Blood Advances
|
July 27, 2022
Gender and early-career faculty disparities in hematology and oncology board review lecture series
Sebawe Syaj, Leen Al-Kraimeen, Marah Akhdar, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 19, 2021
How to Treat High-Risk Myeloma at Diagnosis and Relapse
Jessica Caro, Samer Al Hadidi, Saad Usmani, et al.
Rheumatology International
|
January 4, 2025
Safety and efficacy of CAR-T cell therapy in patients with autoimmune diseases: a systematic review
Lakshmi Kattamuri, Bhavesh Mohan Lal, Nikhil Vojjala, et al.
Journal of Cancer Policy
|
December 20, 2022
Analysis of repeated roles in editorial boards at oncology focused journals
Lama Sawalha, Amar H Kelkar, Ghulam Rehman Mohyuddin, et al.
Journal of Oncology
|
August 17, 2018
Clinical and Molecular Characteristics Associated with Survival in Advanced Melanoma Treated with Checkpoint Inhibitors
Sunil Badami, Sunil Upadhaya, Ravi Kanth Velagapudi, et al.
Ejhaem
|
June 19, 2024
B-cell maturation antigen-based therapies post-talquetamab in relapsed or refractory multiple myeloma
Asis Shrestha, Marah Alzubi, Jawad Alrawabdeh, et al.
Journal of Cancer Policy
|
July 19, 2023
Under-representation of black patients with multiple myeloma in studies supporting International Myeloma Working Group guidelines
Suhib Fahmawi, Carolina Schinke, Sharmilan Thanendrarajan, et al.
Ejhaem
|
August 19, 2024
Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab
Syed Naqvi, Asis Shrestha, Marah Alzubi, et al.
JAMA Network Open
|
August 26, 2022
Geographic and Racial Disparities in Access to Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials for Multiple Myeloma
Raghad Alqazaqi, Carolina Schinke, Sharmilan Thanendrarajan, et al.
American Journal of Hematology
|
March 31, 2022
First- versus second-generation Bruton tyrosine kinase inhibitors in Waldenström's Macroglobulinemia: A systematic review and meta-analysis
Hassan Abushukair, Sebawe Syaj, Obada Ababneh, et al.
Page
of 10